In the United States, the Trump administration and congressional leaders are close to finalizing a deal that would inject approximately $300 billion into a small-business loan program that was overwhelmed with demand and ran out of money. The offer would likewise consist of about $100 billion for medical facilities and coronavirus screening.
Here are some significant advancements:
- Several European nations were preparing to resume some businesses on Monday, in the middle of installing pressure to apprehend rapidly decreasing financial output
- The Centers for Medicare and Medicaid Providers provided standards for physicians to start performing elective medical procedures once again, as part of the progressive reopening of the country.
- President Trump on Sunday defended protesters who are demanding an end to stay-at-home measures, stating that the limitations enacted by some governors “have gone too far.”
- The Food and Drug Administration never vetted dozens of antibody tests on the market, which might lead to confusion over who has established an immune response to covid-19
- President Trump said on Sunday that he might utilize the Defense Production Act to increase production of swabs for screening.
- Extra proof has emerged that the Trump administration was warned about the risk of the coronavirus late last year, undercutting President Trump’s claims that the World Health Organization stopped working to communicate the degree of the danger.